Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC

Aim: Intravesical Bacillus Calmette–Guérin (BCG) is the standard therapy for non-muscle invasive bladder cancer (NMIBC); however, many patients experience recurrence or progression. We examined how urinary immune signals and the urinary microbiome change across BCG and are related to outcomes. Metho...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Yuki Oda, Makito Miyake, Nobutaka Nishimura, Takuto Shimizu, Takuya Owari, Kota Iida, Yasushi Nakai, Nobumichi Tanaka, Kiyohide Fujimoto
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	Open Exploration Publishing Inc. 2026-04-01
श्रृंखला:	Exploration of Targeted Anti-tumor Therapy
विषय:	bacillus calmette–guérin (bcg) therapy non-muscle invasive bladder cancer urinary immune profiling urinary microbiome dynamics firmicutes/bacteroidetes ratio progression-free survival
ऑनलाइन पहुंच:	https://www.explorationpub.com/uploads/Article/A1002365/1002365.pdf
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!